Literature DB >> 30855966

Discovery of Druggability-Improved Analogues by Investigation of the LL-D49194α1 Biosynthetic Pathway.

Lei Dong1,2, Yi Shen3, Xian-Feng Hou3, Wen-Jun Li1,2, Gong-Li Tang3.   

Abstract

The biosynthetic gene cluster of antitumor antibiotic LL-D49194α1 (LLD) was identified and comparatively analyzed with that of trioxacarcins. The tailoring genes encoding glycosyltransferase, methyltransferase and cytochrome P450 were systematically deleted, which led to the discovery of eight compounds from the mutants. Preliminary pharmaceutical evaluation revealed two intermediates exhibiting higher cytotoxicity, stability and solubility. These results highlighted the modification pathway for LLD biosynthesis, and provided highly potent, structurally simplified "unnatural" natural products with improved druggability.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30855966     DOI: 10.1021/acs.orglett.9b00610

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  2 in total

1.  Base excision repair system targeting DNA adducts of trioxacarcin/LL-D49194 antibiotics for self-resistance.

Authors:  Xiaorong Chen; Noah P Bradley; Wei Lu; Katherine L Wahl; Mei Zhang; Hua Yuan; Xian-Feng Hou; Brandt F Eichman; Gong-Li Tang
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

Review 2.  Biosynthesis of DNA-Alkylating Antitumor Natural Products.

Authors:  Qiu-Yue Nie; Yu Hu; Xian-Feng Hou; Gong-Li Tang
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.